Hints and tips:
...At least four companies have tabled bids for the VMIC, including UK biotechnology company Oxford BioMedica, Swiss healthcare manufacturer Lonza, and Japanese conglomerate Fujifilm, according to people familiar...
...(Vanity Fair) News round-up Tesla sends bitcoin to record high with $1.5bn investment (FT) Renesas to buy Apple supplier Dialog for $6bn (FT + Alphaville + Lex) Bain, Cinven agree $4.4bn deal for Lonza...
...A former executive at Swiss group Lonza and Germany’s BASF, he led the Israeli chemicals group on a drive to diversify geographically, through a series of acquisitions and asset disposals....
...Samsung Biologics ranks third behind Lonza of Switzerland and Boehringer Ingelheim of Germany....
...Oppenheimer’s winners included investments in Sartorius and Lonza, European companies that provide services to manufacturers of biotech drugs....
...Arch has $1bn in sales, compared to $3bn at Lonza. Analysts now expect more transactions in the pharma, food and energy sector in the coming months....
...In July, Lonza, a leading life sciences group, asked employees at its key Visp site in Switzerland to work an additional two hours a week, a move eventually accepted by unions to ensure jobs were preserved...
...- Lonza to buy Arch Chemicals for $1.2bn — statement. - Cheung Kong Infrastructure offer 465p a share for Northumbrian Water; due diligence begins — statement....
...Last year Israeli group Teva, the world’s biggest generics maker, and Lonza, its Swiss biotechnology specialist, revealed the start of similar clinical studies on biosimilar rituximab....
...- Corporate: Virgin Media, Smiths News, Rank Group, WH Smith, Balfour Beatty, SAS, ABB, Bluebay Asset Management, Dragon Oil, Rautaruukki, Northern Foods, Falkland Islands Holdings, Publicis, Lonza, Actelion...
...European shares edged up on Monday amid speculation that both Swiss chemicals group Lonza and Dutch electrical equipment supplier Hagemeyer were ripe for takeover....
...Baloise, Lonza, Clariant, Ciba and one of the Swatch shares seem most likely to go, along with Serono, which would have disappeared anyway after its takeover by Germany’s Merck....
International Edition